KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Capital Expenditures (2016 - 2025)

Sabra Health Care REIT (SBRA) has 15 years of Capital Expenditures data on record, last reported at $151.4 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 525.37% year-over-year to $151.4 million; the TTM value through Dec 2025 reached $452.9 million, up 231.99%, while the annual FY2025 figure was $452.9 million, 231.99% up from the prior year.
  • Capital Expenditures reached $151.4 million in Q4 2025 per SBRA's latest filing, down from $288.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $288.0 million in Q3 2025 and bottomed at -$29.5 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $41.4 million, with a median of $17.0 million recorded in 2023.
  • Peak YoY movement for Capital Expenditures: crashed 179.05% in 2022, then skyrocketed 859.94% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $37.3 million in 2021, then tumbled by 179.05% to -$29.5 million in 2022, then skyrocketed by 171.36% to $21.1 million in 2023, then increased by 14.93% to $24.2 million in 2024, then surged by 525.37% to $151.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $151.4 million in Q4 2025, $288.0 million in Q3 2025, and $5.7 million in Q2 2025.